Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay
Authors:
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (8) , 1751-1758
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of China
- National Key R&D Program of China (2017YFB0202600, 2015CB910304)
- National Natural Science Foundation of China (21472208, 81625022, 81430084, 81703415)
- Shanghai Sailing Program (17YF1423100)
This publication has 37 references indexed in Scilit:
- New lysine methyltransferase drug targets in cancerNature Biotechnology, 2012
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- The diverse functions of Dot1 and H3K79 methylationGenes & Development, 2011
- Readers of histone modificationsCell Research, 2011
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemiaGenes & Development, 2008
- Histones and histone modificationsCurrent Biology, 2004
- Epigenetic Consequences of Nucleosome DynamicsCell, 2002
- Methylation of H3-Lysine 79 Is Mediated by a New Family of HMTases without a SET DomainCurrent Biology, 2002
- Translating the Histone CodeScience, 2001
- The language of covalent histone modificationsNature, 2000